Impact of Meditation on Bothersome Tinnitus
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03711630 |
Recruitment Status :
Completed
First Posted : October 18, 2018
Last Update Posted : October 22, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Tinnitus Noise Induced Tinnitus Tinnitus, Subjective Tinnitus, Objective Tinnitus Aggravated Tinnitus, Pulsatile Tinnitus, Spontaneous Oto-Acoustic Emission Tinnitus, Clicking Tinnitus, Tensor Tympani Induced | Behavioral: Meditation | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 27 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Intervention Model Description: | This study is a non-randomized interventional study in which subjects with bothersome tinnitus will meditate to investigate how meditation effects the level of bother of their tinnitus. |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Impact of Meditation on Bothersome Tinnitus |
Actual Study Start Date : | October 6, 2018 |
Actual Primary Completion Date : | February 23, 2019 |
Actual Study Completion Date : | March 21, 2020 |
Arm | Intervention/treatment |
---|---|
Experimental: Meditation
The study cohort will participate in self-guided meditation practice over the course of eight weeks.
|
Behavioral: Meditation
Meditation practice will be through the InsightTimer smart device application. Participants will choose what types of meditation practices they will engage in and report their time spent meditating via REDCap. |
- Tinnitus Handicap Questionnaire (Change in Bother from Tinnitus Over Time) [ Time Frame: Week 1, Week 3, Week 8 ]A measure of degree of bother imposed by tinnitus on the patient.
- Tinnitus Handicap Inventory [ Time Frame: Week 1, Week 3, Week 8 ]A measure of degree of bother imposed by tinnitus on the patient.
- Hospital Anxiety and Depression Scale [ Time Frame: Week 1, Week 3, Week 8 ]
A scale to determine the degree and impact of a participant's anxiety and depression.
Scoring:
Total score: Depression (D) ___________ Anxiety (A) ______________ 0-7 = Normal 8-10 = Borderline abnormal (borderline case) 11-21 = Abnormal (case) 16-21 = exclusionary for participation in this study
- Tinnitus Functional Index [ Time Frame: Week 1, Week 3, Week 8 ]A measure of degree of bother imposed by tinnitus on the patient.
- Mindful Attention Awareness Scale [ Time Frame: Week 1, Week 3, Week 8 ]
A measure to determine the degree of mindful attention the participant utilizes in their lives during the course of the study.
To score the scale, simply compute a mean of the 15 items. Higher scores reflect higher levels of dispositional mindfulness.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Adults, age 18 and above, self-reporting bothersome tinnitus lasting longer than three months.
-
Have been evaluated by an audiologist or otologist.
- Those willing and able to utilize their own smart device or computer meeting the following requirements. For Mac: Requires iOS 10.0 or later. Compatible with iPhone, iPad, and iPod touch.
- For Android: varies by device.
- Data and/or Wi-Fi access
Exclusion Criteria:
- Individuals with meditation training or consistent meditation practice (practice that totals more than 20 minutes daily) within the past six months.
- Those indicated by the Hospital Anxiety and Depression Scale to have "abnormal" indications for anxiety or depression.
- Those with any conditions that would restrict them from being able to either sit, walk, or lie down for at least 30 minutes at a time.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03711630
United States, New York | |
University at Buffalo | |
Buffalo, New York, United States, 14226 |
Documents provided by Brendan P. Fitzgerald, State University of New York at Buffalo:
Responsible Party: | Brendan P. Fitzgerald, Principal Investigator, State University of New York at Buffalo |
ClinicalTrials.gov Identifier: | NCT03711630 |
Other Study ID Numbers: |
STUDY00002602 |
First Posted: | October 18, 2018 Key Record Dates |
Last Update Posted: | October 22, 2020 |
Last Verified: | October 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | This study will not share IPD beyond authors within this study. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Tinnitus Hearing Disorders Ear Diseases Otorhinolaryngologic Diseases |
Sensation Disorders Neurologic Manifestations Nervous System Diseases |